Tofacitinib, as a JAK inhibitor, is mainly used for the treatment of autoimmune diseases such as rheumatoid arthritis, with significant therape...
Tofacitinib is a JAK inhibitor, and common side effects include increased risk of infection, gastrointestinal reactions, dyslipidemia, etc. In ...
When taking Neratinib, attention should be paid to the impact of diet on drug absorption and adverse reactions. Reasonable dietary adjustments ...
The management of vomiting after taking Neratinib requires different measures based on the time of vomiting, with the core principle being to a...
The use of Darolutamide in special populations requires adjusting the dosage or strengthening monitoring according to individual circumstances,...
Darolutamide is a novel androgen receptor inhibitor primarily used for the treatment of non metastatic castration resistant prostate cancer (nm...
Kisqali is a CDK4/6 inhibitor, which is mainly used for the treatment of specific breast cancer. When using Kisqali, attention should be paid t...
Kisqali showed significant efficacy in the treatment of HR+/HER2 breast cancer, but it is necessary to standardize the drug withdrawal process ...
The contraindications, foods, and restrictions of Rezdifra must be strictly followed to ensure medication safety. 1 Taboo population (1) ...
The side effects of Rezdifra can be divided into two categories: common reactions and severe reactions, which can be effectively alleviated thr...